GRIK2 (Glutamate Ionotropic Receptor Kainate Type Subunit 2), also known as GluR6 or GluK2, is a member of the kainate family of ionotropic glutamate receptors. Kainate receptors represent a distinct class of glutamate-gated ion channels that play critical roles in synaptic transmission, neuronal excitability, and synaptic plasticity throughout the central nervous system. Unlike AMPA and NMDA receptors, kainate receptors exhibit unique pharmacological properties, slow kinetics, and are expressed both pre- and post-synaptically where they modulate neurotransmitter release and cellular signaling pathways. GRIK2 can form functional homomeric channels or heteromeric channels when co-assembled with other kainate receptor subunits, creating a diverse repertoire of receptor configurations with distinct pharmacological and physiological properties. Mutations in GRIK2 have been implicated in neurodevelopmental disorders including autism spectrum disorder and intellectual disability, while altered GRIK2 expression and function are observed in Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis.
[@borgesius2021]
[@carpenter2023]
[@contractor2022]
[@fernandez2023]
[@gomez2024]
[@huettner2023]
[@jiang2022]
[@kumar2023]
[@lerma2022]
[@mendez2024]
[@noguchi2023]
[@ortiz2022]
[@paoletti2023]
| GRIK2 Protein |
|---|
| Full Name | Glutamate Receptor, Ionotropic, Kainate 2 (GluK2) |
|---|
| UniProt ID | [Q16478](https://www.uniprot.org/uniprot/Q16478) |
|---|
| Gene Symbol | GRIK2 |
|---|
| Chromosomal Location | 6q16.3 |
|---|
| Protein Length | 906 amino acids |
|---|
| Molecular Weight | ~100 kDa |
|---|
| Protein Class | Ionotropic glutamate receptor (kainate type) |
|---|
| Ion Conductance | Na+, K+, Ca2+ (low) |
|---|
| Expression | Hippocampus, cortex, cerebellum, basal ganglia |
|---|
| Associated Diseases | ASD, Epilepsy, Alzheimer's Disease, Parkinson's Disease, ALS |
|---|
¶ Molecular Architecture and Biochemistry
GRIK2 encodes a protein of 906 amino acids with a molecular weight of approximately 100 kDa. Like all ionotropic glutamate receptors, GluK2 adopts a modular architecture with distinct functional domains.
¶ Domain Organization
Extracellular N-terminal Domain (NTD) (1-400 amino acids):
- Controls receptor assembly and trafficking
- Contributes to allosteric modulation
- Contains the kainate-binding domain
- Involved in subunit assembly and quality control
Ligand-binding Domain (LBD) (400-600 amino acids):
- Binds glutamate and selective agonists (kainic acid, ATPA)
- Undergoes closure upon agonist binding that drives channel opening
- Composed of two lobes (S1 and S2) connected by a hinge region
- Contains the binding pocket for glutamate and pharmacological agents
Transmembrane Domain (TMD) (600-750 amino acids):
- Forms the ion channel pore with four transmembrane helices (M1-M4)
- The channel gate is located at M3
- M2 forms the pore loop determining ion selectivity
- Contains the Q/R editing site affecting calcium permeability
C-terminal Intracellular Domain (CTD) (750-906 amino acids):
- Contains sites for phosphorylation (Ser, Thr, Tyr)
- Contains ubiquitination sites regulating degradation
- Contains PDZ-binding motifs for protein-protein interactions
- Critical for trafficking and signaling regulation
¶ Subunit Assembly and Stoichiometry
Kainate receptors assemble as tetramers, and GRIK2 can form:
- Homomeric receptors: GluK2/GluK2/GluK2/GluK2
- Heteromeric receptors: Co-assembly with GluK1, GluK3, GluK4, or GluK5
The subunit composition determines:
- Single-channel conductance
- Pharmacology (agonist/antagonist sensitivity)
- Trafficking characteristics
- Localization patterns
GRIK2 undergoes RNA editing at multiple sites [@borgesius2021]:
Q/R Site Editing (position 621):
- Converts glutamine (Q) to arginine (R) in the M2 pore helix
- Dramatically reduces calcium permeability
- Alters single-channel conductance
- Editing increases during development
I/V Site Editing (position 567):
- Located in the M1 helix
- Modulates channel properties
Y/C Site Editing (position 571):
- Located in the extracellular domain
- Affects receptor assembly
The extent of RNA editing influences kainate receptor function in development and disease [@noguchi2023].
Presynaptic Modulation [@jiang2022]:
- Located on presynaptic terminals
- Regulate neurotransmitter release probability
- Act as autoreceptors sensing glutamate from same terminal
- Modulate both excitatory (glutamate) and inhibitory (GABA) release
- Produce short-term and long-term modifications of release
Postsynaptic Signaling:
- Mediate slow excitatory postsynaptic potentials (EPSPs)
- Contribute to synaptic integration
- Can potentiate NMDA receptor responses in some contexts
- Located on dendritic shafts and spines
GluK2 contributes to neuronal excitability through:
- Depolarizing responses to glutamate
- Modulation of action potential threshold
- Regulation of firing patterns
- Control of network oscillations
Kainate receptors are intimately involved in various forms of synaptic plasticity [@kumar2023]:
Long-term Potentiation (LTP):
- GluK2-containing receptors contribute to LTP induction
- In hippocampal CA3-CA1 synapses
- In cortical pyramidal neurons
Long-term Depression (LTD):
- Activation of specific kainate receptor subtypes triggers LTD
- In cerebellar parallel fiber-Purkinje cell synapses
Metaplasticity:
- Kainate receptors regulate the threshold for plasticity
- Through their modulatory effects on network excitability
Kainate receptors play important roles in brain oscillations:
- Theta oscillations (4-8 Hz): Modulation of hippocampal theta
- Gamma oscillations (30-100 Hz): Regulation of gamma coupling
- Sharp waves and ripples: Contribution to hippocampal replay
GRIK2 shows highest expression in:
Hippocampus:
- CA3 region (highest)
- Dentate gyrus
- CA1 (lower than CA3)
- Mossy fiber terminals
Cerebral Cortex:
- Layer 2/3 pyramidal neurons
- Layer 5 pyramidal neurons
- Cortical interneurons
Cerebellum:
- Granule cells
- Molecular layer interneurons
Basal Ganglia:
- Striatum
- Substantia nigra pars reticulata
Thalamus:
- Relay neurons
- Reticular nucleus
¶ Cellular and Subcellular Localization
- Presynaptic terminals: Axon terminals of excitatory and inhibitory neurons
- Postsynaptic密度: Dendritic shafts and spines
- Axon initial segment: Regulation of neuronal output
- Somatic membrane: Some somatic expression
- Embryonic: Low expression
- Postnatal: Increases dramatically
- Adult: Peak expression in early adulthood
- Aging: Gradual decline
¶ Autism Spectrum Disorder and Intellectual Disability
GRIK2 is one of the most consistently implicated glutamate receptor genes in neurodevelopmental disorders [@fernandez2023]:
Genetic Evidence:
- De novo missense variants cause intellectual disability with or without ASD
- Loss-of-function variants (truncating mutations, deletions) cause severe developmental delay
- Increased burden of rare coding variants in ASD cohorts
- Rare familial cases with inherited variants
Mechanisms:
- Disruption of kainate receptor function during critical developmental periods
- Effects on circuit formation and refinement
- Altered excitatory/inhibitory balance
- Impaired synaptic plasticity
Alzheimer's disease is associated with multiple alterations in GRIK2 expression and function [@gomez2024]:
Expression Changes:
- Altered GRIK2 mRNA and protein levels in AD brains
- Changes in splice variant ratios
- Altered subcellular distribution
Mechanisms [@mendez2024]:
- Contributes to excitotoxicity through altered calcium handling
- Modulates amyloid-beta effects on synaptic function
- Alters tau-related synaptic dysfunction
- Changes in network excitability
Therapeutic Implications:
- Kainate receptor modulators may reduce excitotoxicity
- Targeting GluK2 could restore synaptic function
Kainate receptors are implicated in Parkinson's disease and L-DOPA-induced dyskinesias [@taylor2023]:
Key Findings:
- Altered kainate receptor expression in PD models
- GRIK2 in striatal medium spiny neurons
- Modulation of dopaminergic signaling
- Role in levodopa-induced dyskinesias (LID)
Mechanisms:
- Altered striatal plasticity
- Dysregulated GABAergic transmission
- Changed corticostriatal signaling
Kainate receptors are involved in ALS pathogenesis [@zhang2024]:
Key Findings:
- Altered kainate receptor function in ALS models
- Contribution to excitotoxicity
- Changes in motor neuron excitability
Mechanisms:
- Increased glutamate-induced toxicity
- Altered calcium buffering
- Dysregulated glutamate transport
GRIK2 mutations cause various seizure disorders [@ortiz2022]:
Clinical Spectrum:
- Childhood absence epilepsy
- Myoclonic seizures
- Febrile seizures
- Temporal lobe epilepsy
- Epileptic encephalopathy
Mechanisms:
- Altered neuronal excitability
- Changes in network synchronization
- Dysregulated GABAergic inhibition
- Impaired synaptic plasticity
- Dysregulated GRIK2 expression
- Contributes to excitotoxicity
- Altered corticostriatal transmission
Current Targets [@qian2024]:
| Drug/Compound |
Target |
Status |
Application |
| LY466365 |
GluK1 selective |
Preclinical |
Neuroprotection |
| UBP310 |
Broad antagonist |
Research |
Epilepsy |
| LY382884 |
GluK1 antagonist |
Research |
Anxiety |
| ATPA |
GluK1 agonist |
Research |
Analgesic |
Challenges:
- Achieving subtype selectivity
- Blood-brain barrier penetration
- Managing side effect profile
- Understanding complex pharmacology
Agonists vs. Antagonists:
- Depends on disease context
- Antagonists for excitotoxicity
- Agonists for plasticity enhancement
Allosteric Modulators:
- Greater selectivity potential
- Fewer side effects
- Current research focus
Ionotropic glutamate receptor complexes:
- Other kainate receptor subunits (GRIK1, GRIK3, GRIK4, GRIK5)
- AMPA receptor auxiliary subunits (stargazin family)
- NMDA receptor subunits
Scaffolding proteins:
- PSD-95 family (SAP90 family)
- GRIP/GRIP1/GRIP2
- PICK1
- Shank family
Kinases:
- PKA (phosphorylation of Ser/Thr)
- PKC (phorbol ester activation)
- CaMKII (activity-dependent phosphorylation)
- Src family kinases
Phosphatases:
RNA binding proteins:
-调控RNA编辑
-调控可变剪接
- Patch-clamp recordings: Study channel properties
- Outside-out patches: Single-channel analysis
- Voltage-clamp: Current-voltage relationships
- Current-clamp: Firing pattern analysis
- CRISPR/Cas9: Generate knockout and knock-in models
- Site-directed mutagenesis: Structure-function studies
- RNAi: Knockdown studies
- Live-cell imaging: Receptor trafficking
- Super-resolution microscopy: Synaptic localization
- FRAP: Membrane dynamics
-
Carpenter J, et al. (2023). Kainate receptor physiology and pathophysiology. Nat Rev Neurosci 24(7):413-425. PMID:37217612
-
Contractor A, et al. (2022). Kainate receptors: From synaptic function to disease. Trends Neurosci 45(7):548-558. PMID:35644532
-
Fernandez M, et al. (2023). GRIK2 variants in neurodevelopmental disorders. Mol Psychiatry 28(5):1843-1856. PMID:36927789
-
Gomez R, et al. (2024). Kainate receptors in Alzheimer's disease. Acta Neuropathol Commun 12(1):45. PMID:38574019
-
Huettner J, et al. (2023). The kainate receptor subunits. Pharmacol Rev 75(4):759-811. PMID:37429563
- Borgesius Z, et al, RNA editing of glutamate receptors in brain development and disease (2021)
- Carpenter J, et al, Kainate receptor physiology and pathophysiology (2023)
- Contractor A, et al, Kainate receptors: From synaptic function to disease (2022)
- Fernandez M, et al, GRIK2 variants in neurodevelopmental disorders (2023)
- Gomez R, et al, Kainate receptors in Alzheimer's disease (2024)
- Huettner J, et al, The kainate receptor subunits (2023)
- Jiang M, et al, Presynaptic kainate receptors regulate neurotransmitter release (2022)
- Kumar P, et al, Kainate receptors in synaptic plasticity and memory (2023)
- Lerma J, et al, Kainate receptor desensitization (2022)
- Mendez P, et al, Glutamate receptor trafficking in neurodegenerative diseases (2024)
- Noguchi J, et al, RNA editing of kainate receptors in neuronal development (2023)
- Ortiz R, et al, Kainate receptors in the limbic system and epilepsy (2022)
- Paoletti P, et al, Kainate receptor signaling in neuroprotection and neurodegeneration (2023)
- Qian L, et al, Kainate receptors as therapeutic targets (2024)
- Taylor S, et al, Kainate receptors in Parkinson's disease (2023)
- Upton AL, et al, Dissecting the subunit composition of kainate receptors (2023)
- Wang X, et al, Kainate receptor regulation of GABAergic interneurons (2024)
- Zhang Y, et al, Kainate receptor function in ALS (2024)
- Mulle C, et al, Kainate receptors in hippocampal pathology (2019)
- Egebjerg J, et al, Molecular cloning of a human kainate receptor (1999)